Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:11 AM
Ignite Modification Date:
2025-12-25 @ 5:11 AM
NCT ID:
NCT02586727
Eligibility Criteria:
Inclusion Criteria:
* A Patient must meet the following criteria to be eligible for inclusion in the study:
1. 21 years of age and over
2. 20/800 or better visual acuity
3. Must have received previous treatment for radiation maculopathy within the last 4-26 weeks
4. Any presence of macular edema (evaluated by SD-OCT) caused by radiation retinopathy
5. Willing and able to comply with clinic visits and study-related procedures
6. Provide signed informed consent
Exclusion Criteria:
* A patient who meets any of the following criteria will be excluded from the study:
1. Patients less than 21 years of age.
2. Patients with mental disability or any other condition that precludes the acquisition of an sdOCT image such as (nystagmus, neck disease, etc.)
3. Patients who have previously been treated with intravitreal triamcinolone acetonide for macular edema (signs of recalcitrant disease)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Study:
NCT02586727
Study Brief:
Protocol Section:
NCT02586727